News

Under Armour Transitions with Enhanced Restructuring Plans

Under Armour Transitions with Enhanced Restructuring Plans

Under Armour Announces Updates on Restructuring Plans and Financial Projections

Under Armour, Inc. (NYSE: UAA) has recently provided updates on its restructuring strategy for Fiscal 2025. This initiative is designed to enhance the company's supply chain capabilities while boosting overall business performance. As Under Armour seeks to streamline its operations, the revised plan involves a thorough evaluation of necessary changes to adapt to the competitive market environment.

Initially, the company estimated pre-tax restructuring and related charges to be between $70 million and $90 million. However, following a comprehensive review, Under Armour now anticipates total charges to be around $140 million to $160 million due to strategic decisions, including the closure of one of its major distribution centers, which is expected to take place by 2026. This proactive approach highlights Under Armour's dedication to improving operational efficiency and optimizing business functions.

Breakdown of Restructuring Charges

The financial details regarding the restructuring plan are outlined below:

  • Up to $75 million in cash charges, which includes approximately $30 million set aside for employee severance and benefits. An additional $45 million is allocated for various transformational initiatives.
  • Non-cash charges may total up to $85 million, primarily consisting of about $7 million for employee severance and benefits, with $78 million designated for facility-related and other asset impairments.

During the quarter ending June 30, 2024, Under Armour recorded approximately $34 million of these restructuring and related charges. The distribution of these expenses indicates a proactive approach, as two-thirds of the projected costs under the revised plan are expected to be incurred by the end of Fiscal 2025.

Perspectives from Under Armour Leadership

David Bergman, Chief Financial Officer of Under Armour, highlighted the significance of this initiative, stating, "We continue to proactively identify opportunities to optimize our business to help create a better and stronger Under Armour. Success in restructuring will enhance our brand and drive long-term financial productivity, enabling us to become a more agile and efficient company." This viewpoint underscores the leadership's commitment to overcoming challenges while remaining focused on growth and sustainability.

Revised Financial Outlook for Fiscal 2025

In line with the restructuring efforts, Under Armour has revised its Financial Outlook for Fiscal 2025. The updated expectations include:

  • Operating losses are now projected to range from $220 million to $240 million, a significant increase from previous forecasts. Excluding restructuring charges, the adjusted operating income is anticipated to be between $140 million and $160 million.
  • The diluted loss per share is expected to be between $0.58 and $0.61, revised from earlier estimates of $0.53 to $0.56. Adjusted diluted earnings are now forecasted to be between $0.19 and $0.22.

Clarifying Non-GAAP Financial Metrics

Under Armour has introduced adjusted financial measures in its communications regarding Fiscal 2025. These metrics exclude certain impacts, such as litigation reserves and the effects of the restructuring plan, to provide a clearer view of core operations. Understanding these adjustments is crucial for stakeholders and investors, as they reflect the company's underlying performance without external influences. Management considers these measures essential for evaluating operational health.

Overview of Under Armour, Inc.

Based in Baltimore, Under Armour, Inc. is a leading name in the athletic performance apparel, footwear, and accessories industry. The brand is dedicated to creating innovative products aimed at empowering athletes, emphasizing its mission to enhance human performance at all levels.

Frequently Asked Questions

What are the main goals of Under Armour’s restructuring plan?

The restructuring plan aims to optimize supply chain operations and strengthen overall business performance, allowing Under Armour to navigate competitive challenges effectively.

What financial changes have been announced for Fiscal 2025?

The updated forecast includes increased operating loss projections and revised expectations for diluted earnings per share, reflecting ongoing restructuring efforts.

How has Under Armour's leadership responded to the restructuring challenges?

Under Armour's CFO has emphasized a proactive approach in seeking improvements and enhancing operational efficiency, which is vital for long-term brand strength.

What are adjusted financial measures, and why are they used?

Adjusted financial measures exclude specific non-core costs to provide a more accurate representation of the company's operational performance and financial health.

What is the long-term outlook for Under Armour after these changes?

Under Armour aims to emerge stronger and more efficient following its restructuring, with long-term strategies focused on enhanced performance and brand growth.

About The Author

About Investors Hangout

Investors Hangout is a leading online stock forum for financial discussion and learning, offering a wide range of free tools and resources. It draws in traders of all levels, who exchange market knowledge, investigate trading tactics, and keep an eye on industry developments in real time. Featuring financial articles, stock message boards, quotes, charts, company profiles, and live news updates. Through cooperative learning and a wealth of informational resources, it helps users from novices creating their first portfolios to experts honing their techniques. Join Investors Hangout today: https://investorshangout.com/

The content of this article is based on factual, publicly available information and does not represent legal, financial, or investment advice. Investors Hangout does not offer financial advice, and the author is not a licensed financial advisor. Consult a qualified advisor before making any financial or investment decisions based on this article. This article should not be considered advice to purchase, sell, or hold any securities or other investments. If any of the material provided here is inaccurate, please contact us for corrections.

Top 10 Most Recent News Articles

KINGRVER Boosts RV Comfort with New Water Heater Lineup

Updated Category News Views 9

An Upgrade for the Open Road In the land of RV living, comfort is king—or in this case, KINGRVER. Dropping affordable upgrades for water heaters into the world of RVs, KINGRVER's CT6 lineup is like a warm hug on a chilly campsite morning. Whether you've pulled up to a wooded retreat or parked under the vast desert sky, having dependable hot water shouldn't be a gamble....

Continue Reading
JOYEE N01 Debuts Globally with First 2,000 Deliveries

Updated Category News Views 123

JOYYE N01 Breaks into the Global Market Now, here we go, folks—a Chinese car with ambitions bigger than the Sahara. On October 28, the JOYEE N01 rolled off the assembly line and into the international scene with a lot of fanfare at FAW's Yancheng Branch. Mark my words, this isn't just another model trying to strut into the global auto arena. This event delivered the...

Continue Reading
Ambrosia Biosciences Unveils Promising Nonclinical Metabolic Data

Updated Category News Views 52

Ambrosia's Latest Nonclinical Revelations Ambrosia Biosciences has just thrown out some major bait at ObesityWeek® 2026. The highlight? New nonclinical data profiles for two of their understudy small molecule programs—AMB-895 and AMB-131. It may sound niche, but in this sector, promising data spins heads. Their GLP-1 receptor agonist, AMB-895, and GIP receptor...

Continue Reading
Lilly's Obesity Breakthroughs: A Step Beyond the Scale

Updated Category News Views 422

Pushing the Boundaries of Obesity Treatment Alright, let's cut through the noise and get to what really matters here. Eli Lilly is taking on obesity treatment like it's Clash of the Titans at this year's ObesityWeek 2026 in Washington, D.C. Forget just dropping pounds—Lilly wants to reshape how we think about obesity entirely. They're not just leaning into the scale,...

Continue Reading
Uber Data Breach: Class Action Investigation Begins

Updated Category News Views 175

When Tech Meets Trouble: Uber's Data Breach Picture this: the hum of Uber rides weaving through your city, drivers none the wiser that personal info has been pried from the vaults thanks to their tech partner, Fireworks AI. Uber, folks, is in hot water once again. This isn’t just another tech hiccup; it's a legal whirlwind brewing up courtesy of Edelson Lechtzin LLP, a...

Continue Reading
Novo's CagriSema Trials Show Promising Weight Loss

Updated Category News Views 104

Decoding CagriSema's Promise Let me tell you, when those corporate folks from Novo Nordisk announce something big like their investigational drug CagriSema at ObesityWeek® 2026, it’s time to take notice. This isn’t just your average press release about some new weight loss fad. We’re talking about a phase 3 REDEFINE 1 trial that opens up a treasure chest of data...

Continue Reading
CVS Study: GLP-1 Drugs Effective But Costly

Updated Category News Views 0

Can GLP-1s Deliver Value at Their Current Price? Alright, folks, here's a real-world gut check from CVS Health. They crunched some numbers using Aetna's anonymized claims data, and the results are eye-opening. These GLP-1s are showing promising health outcomes—lower hospital visits, better clinical results, yada yada. But when it comes to savings, they ain't quite...

Continue Reading
Novo's CagriSema Trial Shows Promising Obesity Results

Updated Category News Views 432

Novo's Latest Weight Loss Gamble Well, look what we have here. Novo Nordisk is shaking up the obesity treatment scene with some bold numbers from their REDEFINE 9 trial. The investigational CagriSema combo of amylin analog and GLP-1 receptor agonist has churned out an eyeball-popping near 21% weight loss. For context, we're staring down the barrel of numbers far meatier...

Continue Reading
Shenzhen's Vision Unveiled: APEC 2026 Promo Debut

Updated Category News Views 287

Shenzhen's Spotlight Moment at APEC 2026 When Shenzhen announced its promotional video for the 2026 APEC Economic Leaders' Meeting, it wasn't just about standard tourism glitz. This was a show of force, a bold step onto the main stage of global politics and economics. The video's launch wasn’t merely an audio-visual delight—it staked a claim in shaping the future...

Continue Reading
YSTUDIO's Pens: A Nod to the Power of Writing

Updated Category News Views 557

Slow Down, Write On: A New Era for Stationery In a world where sentiments zip around with a swipe, here we find YSTUDIO tapping into something analog and profound. Their latest offerings—a 'Brand Day Gift Box' and the 'Inner Universe' pen series—are more than just high-end stationery. They’re an invitation to reconnect with the written word, a gesture to slow our...

Continue Reading

Top 5 Most Recently Viewed Articles

NKGen Biotech to Present Innovative Research at Global Congress

Updated Category News Views 157

NKGen Biotech's Exciting Announcement on Upcoming Presentation NKGen Biotech Inc. (NASDAQ: NKGN), a pioneering clinical-stage biotechnology firm dedicated to developing cutting-edge autologous and allogeneic natural killer cell therapies, has recently shared some thrilling news regarding their participation in an international event. Highlighting Neurodegenerative...

Continue Reading
Celebrating Case Managers: A Call to Action for 2025

Updated Category News Views 522

Recognizing the Contribution of Case Managers in 2025 Case managers have proven time and again to be essential contributors to the health and human services spectrum. In 2025, the two prominent organizations in the case management field—the American Case Management Association (ACMA) and the Commission for Case Manager Certification (CCMC)—have once again partnered to...

Continue Reading
Faruqi & Faruqi Investigates Ford Investor Claims

Updated Category News Views 92

Back in 2024, Faruqi & Faruqi took aim at Ford Motor Company (NYSE: F), investigating claims from investors who’d racked up losses over $100,000. They were diving deep into the financial mess at Ford—a colossal vehicle manufacturer that found itself knee-deep in allegations of breaching federal securities laws. The chatter was all about how quality assurance failures...

Continue Reading
Entourage Health Announces Going-Private Arrangement Plan

Updated Category News Views 236

Entourage Health Corp. Takes a Bold Step Toward Going-Private Entourage Health Corp. (TSX-V: ENTG) (OTCQX: ETRGF) has officially entered into a significant arrangement agreement with 1001007762 Ontario Inc. and 2437653 Ontario Inc. This strategic move, a statutory plan under the Business Corporations Act (Ontario), sees the Purchaser agreeing to acquire all common shares...

Continue Reading
A&W Revenue Royalties Income Fund Q3 2024 Results Review

Updated Category News Views 183

A&W Revenue Royalties Income Fund Q3 2024 Financial Overview TRADING SYMBOL: TSX: AW.UN A&W Revenue Royalties Income Fund has reported encouraging results for the third quarter ending this year. The quarterly performance reflects steady royalty income growth and strategic developments that promise an exciting future. Royalty Income Performance In the third quarter of...

Continue Reading